Colonization of Skin by M. Luteus Q24 Probiotic - Trial NCT06137209
Access comprehensive clinical trial information for NCT06137209 through Pure Global AI's free database. This phase not specified trial is sponsored by BLIS Technologies Limited and is currently Recruitment Completed. The study focuses on Microbial Colonization. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Active Comparator: Study Group A: Blis Q24 Serum at higher dose
Interventional
other
Sponsor & Location
BLIS Technologies Limited
Timeline & Enrollment
N/A
Oct 02, 2023
Mar 15, 2024
Primary Outcome
Change in microbial composition following application of 1e7 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 11 days,Change in skin quality parameters following application of 1e7 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 11 days,Change in microbial composition following application of 1e6 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 11 days,Change in skin quality parameters following application of 1e6 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 11 days,Change in microbial composition following application of 1e7 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 30 days,Change in skin quality parameters following application of 1e7 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 30 days,Change in microbial composition following application of 1e6 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 30 days,Change in skin quality parameters following application of 1e6 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 30 days,Change in microbial composition post 7 days of last application of 1e7 cfu of Micrococcus luteus Q24 in serum.,Change in skin quality parameters post 7 days of last application of 1e7 cfu of Micrococcus luteus Q24 in serum.,Change in microbial composition post 7 days of last application of 1e6 cfu of Micrococcus luteus Q24 in serum.,Change in skin quality parameters post 7 days of last application of 1e6 cfu of Micrococcus luteus Q24 in serum.
Summary
The purpose of this study is to evaluate the skin quality improvement and colonization
 efficacy following the application of probiotic Micrococcus luteus Q24 (BLIS Q24) to the face
 from a serum format in healthy adults.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06137209
Non-Device Trial